Beyond Celiac Investments Announces Funding of RheumaGen to Accelerate Treatments Towards a Cure in Celiac Disease
PR Newswire —
Investment to progress RheumaGen's celiac disease program through early development as a potential transformational gene therapy PHILADELPHIA, Dec. 22, 2025 /PRNewswire/ -- Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, has made a Series A-1 preferred...